Granulation tissue is common in otitis media (OM), yet little is known about the signaling pathways in the formation of granulation tissue in response to infections. In this study, we sought to investigate the activation of the transforming growth factor beta (TGF-β) signaling pathway in the formation of granulation tissue in response to middle ear pathogens.
Methods:
Rat OM models were made by inoculating pneumococcus type 6A or nontypeable Haemophilus influenzae into the middle ear cavity or by obstructing the eustachian tube. Various pathway activities in the middle ear mucosa were analyzed with microarrays.
Results:
The TGF-β signaling pathway was highly regulated in the middle ear cleft with bacterial OM, but not in the ears with eustachian tube obstruction. In ears with bacterial OM, the TGF-β signaling pathway products were higher in Haemophilus-infected ears than in pneumococcus-infected ears.
Conclusions:
Bacterial OM triggers granulation tissue to thrive in the middle ear cleft of rats. Nontypeable H influenzae is more potent than pneumococcus type 6A in the formation of granulation tissue. Eustachian tube obstruction alone did not contribute to granulation tissue formation in the middle ear.
LinJTsuboiYPanWGiebinkGSAdamsGLKimY. Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection. Int J Pediatr Otorhinolaryngol2002;65:203–11.
2.
LydenDYoungAZZagzagD. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature1999;401:670–7.
3.
VolpertOVPiliRSikderHA. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell2002;2:473–83.
4.
NishiyamaKTakajiKKataokaK. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation2005;112:2840–50.
5.
OhnoINittaYYamauchiK. Transforming growth factor beta 1 (TGF β1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol1996;15:404–9.
6.
BlobeGCSchiemannWPLodishHF. Role of transforming growth factor beta in human disease. N Engl J Med2000;342:1350–8.
7.
ZavadilJBitzerMLiangD. Genetic programs of epithelial cell plasticity directed by transforming growth factor–beta. Proc Natl Acad Sci U S A2001;98:6686–91.
8.
SchnaperHWHayashidaTHubchakSCPonceletAC. TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol2003;284:F243–F252.
9.
OlmanMAMatthayMA. Transforming growth factor–β induces fibrosis in immune cell–depleted lungs. Am J Physiol Lung Cell Mol Physiol2003;285:L522–L526.
10.
ClancyRMBuyonJP. Clearance of apoptotic cells: TGF-β in the balance between inflammation and fibrosis. J Leukoc Biol2003;74:959–60.
11.
FlandersKC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol2004;85:47–64.
12.
GronebergDAWittHAdcockIMHansenGSpringerJ. Smads as intracellular mediators of airway inflammation. Exp Lung Res2004;30:223–50.
13.
DingLXuJLuoXCheginiN. Gonadotropin releasing hormone and transforming growth factor β activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor–1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab2004;89:5549–57.
14.
DerynckRZhangYE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature2003;425:577–84.
15.
KondoSKagamiSUrushiharaM. Transforming growth factor–β1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts. Biochim Biophys Acta2004;1693:91–100.
16.
XuJLuoXCheginiN. Differential expression, regulation, and induction of Smads, transforming growth factor–β signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab2003;88:1350–61.
17.
SinghJLingLESawyerJSLeeWCZhangFYinglingJM. Transforming the TGF-β pathway: Convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5). Curr Opin Drug Discov Devel2004;7:437–45.
18.
WangDParkJSChuJS. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor β1 stimulation. J Biol Chem2004;279:43725–34.
19.
MinshallEMLeungDYMartinRJ. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol1997;17:326–33.
20.
VignolaAMChanezPChiapparaG. Transforming growth factor–β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med1997;156:591–9.
21.
RankinJAPicarellaDEGebaGP. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A1996;93:7821–5.
22.
LeeJJMcGarryMPFarmerSC. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med1997;185:2143–56.
23.
TemannUAGebaGPRankinJAFlavellRA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyper-responsiveness. J Exp Med1998;188:1307–20.
24.
ZhuZHomerRJWangZ. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest1999;103:779–88.
25.
RobertsABMcCuneBKSpornMB. TGF-β: Regulation of extracellular matrix. Kidney Int1992;41:557–9.
26.
CordeiroMFBhattacharyaSSSchultzGSKhawPT. TGF-β1, -β2, and -β3 in vitro: Biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci2000;41:756–63.
KawanoHHarutaATsuboiY. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: The pathologic basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol2002;111:415–22.
29.
TsuboiYKimYGiebinkGS. Induction of mucous cell metaplasia in the middle ear of rats using a three-step method: An improved model for otitis media with mucoid effusion. Acta Otolaryngol2002;122:153–60.
30.
ToyamaKKimYPaparellaMMLinJ. Temperature-sensitive SV40-immortalized rat middle ear epithelial cells. Ann Otol Rhinol Laryngol2004;113:967–74.
van HogerlindenMRozellBLAhrlund-RichterLToftgårdR. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor–kappaB signaling. Cancer Res1999;59:3299–303.
33.
LinJHoSShekelsLPaparellaMMKimY. Mucin gene expression in the rat middle ear: An improved method for RNA harvest. Ann Otol Rhinol Laryngol1999;108:762–8.
34.
DerynckRZhangYFengXH. Smads: Transcriptional activators of TGF-β responses. Cell1998;95:737–40.
35.
PhippsSBenyahiaFOuTTBarkansJRobinsonDSKayAB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol2004;31:626–32.
36.
TateossianHHardisty-HughesREMorseS. Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics2009;2:5.
37.
JonoHShutoTXuH. Transforming growth factor–β–Smad signaling pathway cooperates with NF–kappa B to mediate nontypeable Haemophilus influenzae–induced MUC2 mucin transcription. J Biol Chem2002;277:45547–57.
38.
SpornMBRobertsABWakefieldLMAssoianRK. Transforming growth factor–β: Biological function and chemical structure. Science1986;233:532–4.
